Results 251 to 260 of about 44,809 (280)
Some of the next articles are maybe not open access.

Plasmapheresis in Hyperviscosity Syndrome

Acta Medica Scandinavica, 1985
ABSTRACT Three patients with Waldenström's macroglobulinaemia developed circulatory complications due to increased plasma viscosity, i.e relative viscosity value above 4. Plasmapheresis was performed either in a Haemonetics 30 S cell separator, by plasma filtration through a CPS 10 TM filter or by a double‐double pack Fenwal® system.
Erik Hippe   +3 more
openaire   +3 more sources

Plasmapheresis Technology

Vox Sanguinis, 1986
Abstract. Manual plasmapheresis is done worldwide on both paid donors, and to a much smaller extent on volunteer donors in order to generate source plasma to be fractionated into albumin, clotting factor concentrates, and gamma globulin. Automated technology has now been developed utilizing both centrifugal, and membrane separation devices (Haemonetics
openaire   +2 more sources

Plasmapheresis in nephrology: an update

Current Opinion in Nephrology & Hypertension, 2006
In the past, recommendations for the use of plasmapheresis were based on findings reported from pilot studies or anecdotes. New results from several randomized controlled trials have changed the indications for the use of plasma exchange.A large randomized controlled study of patients with antineutrophil cytoplasmic antibody associated vasculitis ...
Tahmina Rahman, Lorraine Harper
openaire   +2 more sources

Plasmapheresis in the Dysproteinemias

Therapeutic Apheresis, 2002
Abstract: The dysproteinemias consist of a broad range of serious disease states with the common thread of excessive production of an abnormal, or para‐protein. Various clinical syndromes may arise, either from the underlying disease process, the excess paraprotein, or both.
openaire   +3 more sources

Plasmapheresis in a Patient With Scleromyxedema

Archives of Dermatology, 1987
We describe a patient with progressive scleromyxedema who failed to respond to previously described treatment modalities. A trial of plasmapheresis was initiated, but after an initial promising response, his disease continued to progress. The skin involvement appeared to progress even more rapidly after the plasmapheresis was discontinued.
Donald P. Lookingbill, Alan I. Westheim
openaire   +3 more sources

Therapeutic plasmapheresis

Seminars in Veterinary Medicine and Surgery: Small Animal, 1997
Plasmapheresis is the process by which plasma containing components causing or thought to cause disease is removed from the circulation, and the remaining blood components are returned with plasma or a harmless plasma substitute to the donor. It primarily removes protein-bound solutes or high-molecular-weight solutes such as circulating protein-bound ...
openaire   +2 more sources

Plasmapheresis in the management of psoriasis

Archives of Dermatological Research, 1985
Comme la plasmapherese en impose beaucoup au malade, est couteuse et n'offre qu'une amelioration a court terme, elle n'est pas adaptee comme modalite therapeutique outre dans le traitement du ...
R. Schuster, M. Raff, R. Lenzhofer
openaire   +3 more sources

Volume Limitations of Plasmapheresis

Vox Sanguinis, 1977
Abstract. The published specifications of the acceptable limits of the maximum plasma volume to be ‘harvested’ by plasmapheresis from one individual per year vary from 10–15 liters in Europe to 50–60 liters in the United States. To answer the question which of these widely diverging precepts is appropriate, the effects of plasmapheresis on serum ...
openaire   +3 more sources

Plasmapheresis‐Related Hypotension

Artificial Organs, 2000
Abstract: Hypotension is an uncommon complication of procedures involving extracorporeal circulation, including plasmapheresis. From November 1993 to March 1999, we treated 139 patients who underwent a total of 1,137 sessions of double filtration plasmapheresis (DFP).
Hou-Chang Chiu, Jiann-Horng Yeh
openaire   +2 more sources

Plasmapheresis Therapy of Pemphigus

Archives of Dermatology, 1988
Systemic corticosteroids are the cornerstone of pemphigus therapy. Their use has transformed an almost invariably fatal illness into one whose mortality is less than 10%, probably closer to 5%. 1 However, the serious side effects associated with the prolonged and high doses of corticosteroids required to treat pemphigus have prompted a search for ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy